Latest Alpha 1 antitrypsin

in: Genetically Modified Organisms

Inspector's Report

Year: 2010

All documentation submitted in respect of this notification was taken into consideration by the EPA inspector in her report to the Board of the Agency.

GMO Register Entry

Year: 2010

The GMO Register Entry provides significant details of the clinical trial.

Consent Conditions

Year: 2010

Consent Conditions G0362-01 issued to Applied Genetics Technologies Corporation, USA, to carry out a clinical trial on patients suffering from alpha-1 antitrypsin deficiency, using a Genetically Modified Micro-Organism (GMM). This trial did not proceed.